Literature DB >> 30097251

A machine learning-based prediction model of H3K27M mutations in brainstem gliomas using conventional MRI and clinical features.

Chang-Cun Pan1, Jia Liu2, Jie Tang1, Xin Chen1, Fang Chen2, Yu-Liang Wu1, Yi-Bo Geng1, Cheng Xu1, Xinran Zhang2, Zhen Wu1, Pei-Yi Gao3, Jun-Ting Zhang1, Hai Yan4, Hongen Liao5, Li-Wei Zhang6.   

Abstract

BACKGROUND: H3K27M is the most frequent mutation in brainstem gliomas (BSGs), and it has great significance in the differential diagnosis, prognostic prediction and treatment strategy selection of BSGs. There has been a lack of reliable noninvasive methods capable of accurately predicting H3K27M mutations in BSGs.
METHODS: A total of 151 patients with newly diagnosed BSGs were included in this retrospective study. The H3K27M mutation status was obtained by whole-exome, whole-genome or Sanger's sequencing. A total of 1697 features, including 6 clinical parameters and 1691 imaging features, were extracted from pre- and post-contrast T1-weighted and T2-weighted images. Using a random forest algorithm, 36 selected MR image features were integrated with 3 selected clinical features to generate a model that was predictive of H3K27M mutations. Additionally, a simplified prediction model comprising the Karnofsky Performance Status (KPS) at diagnosis, symptom duration at diagnosis and edge sharpness on T2 was established for practical clinical utility using the least squares estimation method.
RESULTS: H3K27M mutation was an independent prognostic factor that conferred a worse prognosis (p = 0.01, hazard ratio = 3.0, 95% confidence interval [CI], 1.57-5.74). The machine learning-based model achieved an accuracy of 84.44% (area under the curve [AUC] = 0.8298) in the test cohort. The simplified model achieved an AUC of 0.7839 in the test cohort.
CONCLUSIONS: Using conventional MRI and clinical features, we established a machine learning-based model with high accuracy and a simplified model with improved clinical utility to predict H3K27M mutations in BSGs.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brainstem glioma; H3K27M; MRI; Machine earning; Prediction

Mesh:

Substances:

Year:  2018        PMID: 30097251     DOI: 10.1016/j.radonc.2018.07.011

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  12 in total

1.  Prediction of H3K27M-mutant brainstem glioma by amide proton transfer-weighted imaging and its derived radiomics.

Authors:  Zhizheng Zhuo; Liying Qu; Peng Zhang; Liwei Zhang; Yaou Liu; Yunyun Duan; Dan Cheng; Xiaolu Xu; Ting Sun; Jinli Ding; Cong Xie; Xing Liu; Sven Haller; Frederik Barkhof
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-16       Impact factor: 9.236

Review 2.  Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma.

Authors:  Kyle Wierzbicki; Karthik Ravi; Andrea Franson; Amy Bruzek; Evan Cantor; Micah Harris; Morgan J Homan; Bernard L Marini; Abed Rahman Kawakibi; Ramya Ravindran; Rodrigo Teodoro; Viveka Nand Yadav; Carl Koschmann
Journal:  Curr Oncol Rep       Date:  2020-02-06       Impact factor: 5.075

3.  Radiogenomics of diffuse intrinsic pontine gliomas (DIPGs): correlation of histological and biological characteristics with multimodal MRI features.

Authors:  Raphaël Calmon; Volodia Dangouloff-Ros; Pascale Varlet; Christophe Deroulers; Cathy Philippe; Marie-Anne Debily; David Castel; Kevin Beccaria; Thomas Blauwblomme; David Grevent; Raphael Levy; Charles-Joris Roux; Yvonne Purcell; Ana Saitovitch; Monica Zilbovicius; Christelle Dufour; Stéphanie Puget; Jacques Grill; Nathalie Boddaert
Journal:  Eur Radiol       Date:  2021-05-18       Impact factor: 5.315

Review 4.  How Machine Learning is Powering Neuroimaging to Improve Brain Health.

Authors:  Nalini M Singh; Jordan B Harrod; Sandya Subramanian; Mitchell Robinson; Ken Chang; Suheyla Cetin-Karayumak; Adrian Vasile Dalca; Simon Eickhoff; Michael Fox; Loraine Franke; Polina Golland; Daniel Haehn; Juan Eugenio Iglesias; Lauren J O'Donnell; Yangming Ou; Yogesh Rathi; Shan H Siddiqi; Haoqi Sun; M Brandon Westover; Susan Whitfield-Gabrieli; Randy L Gollub
Journal:  Neuroinformatics       Date:  2022-03-28

Review 5.  New Approaches with Precision Medicine in Adult Brain Tumors.

Authors:  Annette Leibetseder; Matthias Preusser; Anna Sophie Berghoff
Journal:  Cancers (Basel)       Date:  2022-01-29       Impact factor: 6.639

6.  Multiparametric MRI-Based Radiomics Model for Predicting H3 K27M Mutant Status in Diffuse Midline Glioma: A Comparative Study Across Different Sequences and Machine Learning Techniques.

Authors:  Wei Guo; Dejun She; Zhen Xing; Xiang Lin; Feng Wang; Yang Song; Dairong Cao
Journal:  Front Oncol       Date:  2022-03-03       Impact factor: 6.244

7.  Magnetic Resonance Imaging Characteristics of Molecular Subgroups in Pediatric H3 K27M Mutant Diffuse Midline Glioma.

Authors:  Annika Hohm; Michael Karremann; Gerrit H Gielen; Torsten Pietsch; Monika Warmuth-Metz; Lindsey A Vandergrift; Brigitte Bison; Annika Stock; Marion Hoffmann; Mirko Pham; Christof M Kramm; Johannes Nowak
Journal:  Clin Neuroradiol       Date:  2021-12-17       Impact factor: 3.649

Review 8.  Imaging diagnosis and treatment selection for brain tumors in the era of molecular therapeutics.

Authors:  Saivenkat Vagvala; Jeffrey P Guenette; Camilo Jaimes; Raymond Y Huang
Journal:  Cancer Imaging       Date:  2022-04-18       Impact factor: 5.605

9.  Artificial intelligence-assisted prediction of preeclampsia: Development and external validation of a nationwide health insurance dataset of the BPJS Kesehatan in Indonesia.

Authors:  Herdiantri Sufriyana; Yu-Wei Wu; Emily Chia-Yu Su
Journal:  EBioMedicine       Date:  2020-04-10       Impact factor: 8.143

10.  Clinical, imaging, and molecular analysis of pediatric pontine tumors lacking characteristic imaging features of DIPG.

Authors:  Jason Chiang; Alexander K Diaz; Lydia Makepeace; Xiaoyu Li; Yuanyuan Han; Yimei Li; Paul Klimo; Frederick A Boop; Suzanne J Baker; Amar Gajjar; Thomas E Merchant; David W Ellison; Alberto Broniscer; Zoltan Patay; Christopher L Tinkle
Journal:  Acta Neuropathol Commun       Date:  2020-04-23       Impact factor: 7.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.